InflammaDry is the first rapid, in-office test that detects elevated levels of the MMP-9 protein in human tears, an inflammatory marker that is consistently elevated in the tears of patients with dry eye disease.
Other dry eye tests only measure tear production and stability. InflammaDry accurately identifies patients with dry eye allowing for optimal treatment methods and better quality of life.
InflammaDry is to be used to aid in the diagnosis of dry
eye, in conjunction with other methods of clinical evaluation.
This test is intended for prescription use at point-of-care sites.